Literature DB >> 16876786

Elongation factor Tu-targeted antibiotics: four different structures, two mechanisms of action.

Andrea Parmeggiani1, Poul Nissen.   

Abstract

Elongation factor Tu (EF-Tu), the carrier of aa-tRNA to the mRNA-programmed ribosome, is the target of four families of antibiotics of unrelated structure, of which the action is supported by two basic mechanisms. Kirromycin and enacyloxin block EF-Tu.GDP on the ribosome; pulvomycin and GE2270 A inhibit the interaction of EF-Tu.GTP with aa-tRNA. The crystallographic analysis has unveiled the structural background of their actions, explaining how antibiotics of unrelated structures and binding modes and sites can employ similar mechanism of action. The selective similarities and differences of their binding sites and the induced EF-Tu conformations make understand how nature can affect the activities of a complex regulatory enzyme by means of low-molecular compounds, and have proposed a suitable approach for drug design.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16876786     DOI: 10.1016/j.febslet.2006.07.039

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  32 in total

1.  Characterization of a novel plasmid-borne thiopeptide gene cluster in Staphylococcus epidermidis strain 115.

Authors:  Philip R Bennallack; Scott R Burt; Michael J Heder; Richard A Robison; Joel S Griffitts
Journal:  J Bacteriol       Date:  2014-10-13       Impact factor: 3.490

2.  A signal relay between ribosomal protein S12 and elongation factor EF-Tu during decoding of mRNA.

Authors:  Steven T Gregory; Jennifer F Carr; Albert E Dahlberg
Journal:  RNA       Date:  2008-12-17       Impact factor: 4.942

3.  Identifying ligand-binding hot spots in proteins using brominated fragments.

Authors:  Morten K Grøftehauge; Martin Ø Therkelsen; Rolf Taaning; Troels Skrydstrup; J Preben Morth; Poul Nissen
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-08-19

Review 4.  Challenges of antibacterial discovery.

Authors:  Lynn L Silver
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

Review 5.  Elongation in translation as a dynamic interaction among the ribosome, tRNA, and elongation factors EF-G and EF-Tu.

Authors:  Xabier Agirrezabala; Joachim Frank
Journal:  Q Rev Biophys       Date:  2009-08       Impact factor: 5.318

Review 6.  Elucidating and engineering thiopeptide biosynthesis.

Authors:  Philip R Bennallack; Joel S Griffitts
Journal:  World J Microbiol Biotechnol       Date:  2017-05-11       Impact factor: 3.312

7.  Elongation factor Ts directly facilitates the formation and disassembly of the Escherichia coli elongation factor Tu·GTP·aminoacyl-tRNA ternary complex.

Authors:  Benjamin J Burnett; Roger B Altman; Ryan Ferrao; Jose L Alejo; Navdep Kaur; Joshua Kanji; Scott C Blanchard
Journal:  J Biol Chem       Date:  2013-03-28       Impact factor: 5.157

Review 8.  Thiazolyl peptide antibiotic biosynthesis: a cascade of post-translational modifications on ribosomal nascent proteins.

Authors:  Christopher T Walsh; Michael G Acker; Albert A Bowers
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

9.  Influenza A virus protein PB1-F2 impairs innate immunity by inducing mitophagy.

Authors:  Ruifang Wang; Yinxing Zhu; Chenwei Ren; Shuaike Yang; Shan Tian; Huanchun Chen; Meilin Jin; Hongbo Zhou
Journal:  Autophagy       Date:  2020-02-11       Impact factor: 16.016

10.  Phenotypic Suppression of Streptomycin Resistance by Mutations in Multiple Components of the Translation Apparatus.

Authors:  Jennifer F Carr; Hannah J Lee; Joshua B Jaspers; Albert E Dahlberg; Gerwald Jogl; Steven T Gregory
Journal:  J Bacteriol       Date:  2015-07-06       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.